Posts

South Korea’s Move to Cover a $70,000-Plus Rare Epilepsy Drug Offers a Window Into the Global Fight Over Access to Lifesaving Medicines

0

Why South Korea’s April Health Insurance Reconciliation Is Stirring Public Anger — and Raising Bigger Questions About Trust

0